Related references
Note: Only part of the references are listed.Exploring the Multifaceted Therapeutic Potential of Withaferin A and Its Derivatives
Tapan Behl et al.
BIOMEDICINES (2020)
Broad-spectrum antitumor properties of Withaferin A: a proteomic perspective
Martin Dom et al.
RSC MEDICINAL CHEMISTRY (2020)
Molecular modulators of celastrol as the keystones for its diverse pharmacological activities
Sin Wi Ng et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Pathways of cellular proteostasis in aging and disease
Courtney L. Klaips et al.
JOURNAL OF CELL BIOLOGY (2018)
Celastrol inhibits cancer metastasis by suppressing M2-like polarization of macrophages
Yuening Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Proteomic characterization of Withaferin A-targeted protein networks for the treatment of monoclonal myeloma gammopathies
Martin Dom et al.
JOURNAL OF PROTEOMICS (2018)
A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F
Shao-Ru Chen et al.
FRONTIERS IN PHARMACOLOGY (2018)
Celastrol Attenuates the Invasion and Migration and Augments the Anticancer Effects of Bortezomib in a Xenograft Mouse Model of Multiple Myeloma
Muthu K. Shanmugam et al.
FRONTIERS IN PHARMACOLOGY (2018)
Competitive profiling of celastrol targets in human cervical cancer HeLa cells via quantitative chemical proteomics
Yiqing Zhou et al.
MOLECULAR BIOSYSTEMS (2017)
Proteasome inhibitors in cancer therapy
Elisabet E. Manasanch et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
New inhibitor targeting human transcription factor HSF1: effects on the heat shock response and tumor cell survival
Nuria Vilaboa et al.
NUCLEIC ACIDS RESEARCH (2017)
The proteasome and proteasome inhibitors in multiple myeloma
Sara Gandolfi et al.
CANCER AND METASTASIS REVIEWS (2017)
Covalent Ligand Discovery against Druggable Hotspots Targeted by Anti-cancer Natural Products
Elizabeth A. Grossman et al.
CELL CHEMICAL BIOLOGY (2017)
Celastrol: A Spectrum of Treatment Opportunities in Chronic Diseases
Rita Cascao et al.
FRONTIERS IN MEDICINE (2017)
AshwaMAX and Withaferin A inhibits gliomas in cellular and murine orthotopic models
Edwin Chang et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Withaferin-A-A Natural Anticancer Agent with Pleitropic Mechanisms of Action
In-Chul Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
The Biology of Proteostasis in Aging and Disease
Johnathan Labbadia et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 84 (2015)
Celastrol induces apoptosis and autophagy via the ROS/JNK signaling pathway in human osteosarcoma cells: an in vitro and in vivo study
H-Y Li et al.
CELL DEATH & DISEASE (2015)
Revisiting Peptide Identification by High-Accuracy Mass Spectrometry: Problems Associated with the Use of Narrow Mass Precursor Windows
Elena Bonzon-Kulichenko et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Executioner Caspase-3 and 7 Deficiency Reduces Myocyte Number in the Developing Mouse Heart
Maria Cardona et al.
PLOS ONE (2015)
Heat shock factor 1 confers resistance to Hsp90 inhibitors through p62/SQSTM1 expression and promotion of autophagic flux
Buddhini Samarasinghe et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Cancerous inhibitor of PP2A is targeted by natural compound celastrol for degradation in non-small-cell lung cancer
Zi Liu et al.
CARCINOGENESIS (2014)
General Statistical Framework for Quantitative Proteomics by Stable Isotope Labeling
Pedro Navarro et al.
JOURNAL OF PROTEOME RESEARCH (2014)
NF-Kappa B Modulation Is Involved in Celastrol Induced Human Multiple Myeloma Cell Apoptosis
Haiwen Ni et al.
PLOS ONE (2014)
Withaferin A Alone and in Combination with Cisplatin Suppresses Growth and Metastasis of Ovarian Cancer by Targeting Putative Cancer Stem Cells
Sham S. Kakar et al.
PLOS ONE (2014)
HSP90 Inhibitors: Current Development and Potential in Cancer Therapy
Katerina Sidera et al.
Recent Patents on Anti-Cancer Drug Discovery (2013)
Using the Heat-Shock Response To Discover Anticancer Compounds that Target Protein Homeostasis
Sandro Santagata et al.
ACS CHEMICAL BIOLOGY (2012)
Celastrol Analogues as Inducers of the Heat Shock Response. Design and Synthesis of Affinity Probes for the Identification of Protein Targets
Lada Klaic et al.
ACS CHEMICAL BIOLOGY (2012)
Celastrol inhibits growth and induces apoptotic cell death in melanoma cells via the activation ROS-dependent mitochondrial pathway and the suppression of PI3K/AKT signaling
Ju-Hye Lee et al.
APOPTOSIS (2012)
HSF1 Drives a Transcriptional Program Distinct from Heat Shock to Support Highly Malignant Human Cancers
Marc L. Mendillo et al.
CELL (2012)
Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells
Radhamani Kannaiyan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation
Jose T. Thaiparambil et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Chemical and Biological Approaches for Adapting Proteostasis to Ameliorate Protein Misfolding and Aggregation Diseases-Progress and Prognosis
Susan L. Lindquist et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
Mechanisms of Resistance to Hsp90 Inhibitor Drugs: A Complex Mosaic Emerges
Peter W. Piper et al.
PHARMACEUTICALS (2011)
Magnetic mesoporous silica spheres for hyperthermia therapy
F. M. Martin-Saavedra et al.
ACTA BIOMATERIALIA (2010)
Withaferin A targets heat shock protein 90 in pancreatic cancer cells
Yanke Yu et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Probing the anticancer mechanism of prospective herbal drug Withaferin A on mammals: a case study on human and bovine proteasomes
Abhinav Grover et al.
BMC GENOMICS (2010)
Celastrol Inhibits Hsp90 Chaperoning of Steroid Receptors by Inducing Fibrillization of the Co-chaperone p23
Ahmed Chadli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Heat shock factors: integrators of cell stress, development and lifespan
Malin Akerfelt et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Inhibiting the transcription factor HSF1 as an anticancer strategy
Luke Whitesell et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
A Refined Method To Calculate False Discovery Rates for Peptide Identification Using Decoy Databases
Pedro Navarro et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Targeting HSP70 for Cancer Therapy
Lorenzo Galluzzi et al.
MOLECULAR CELL (2009)
A Small Molecule Inhibitor of Inducible Heat Shock Protein 70
J. I-Ju Leu et al.
MOLECULAR CELL (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo
Silvia D. Stan et al.
CANCER RESEARCH (2008)
Quantitative analysis of global ubiquitination in HeLa cells by mass spectrometry
David Meierhofer et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Properties of average score distributions of SEQUEST
Salvador Martinez-Bartolome et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
Activation of heat shock and antioxidant responses by the natural product celastrol: Transcriptional signatures of a thiol-targeted molecule
Amy Trott et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells
Tao Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis
Chengkai Dai et al.
CELL (2007)
Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition
Silke Meister et al.
CANCER RESEARCH (2007)
The tumor proteasome is a primary target for the natural anticancer compound withaferin a isolated from Indian Winter Cherry
Huanjie Yang et al.
MOLECULAR PHARMACOLOGY (2007)
Actin microfilament aggregation induced by withaferin A is mediated by annexin II
RR Falsey et al.
NATURE CHEMICAL BIOLOGY (2006)
Celastrols as inducers of the heat shock response and cytoprotection
SD Westerheide et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Share Paper
